[ad_1] Marinomed Biotech AG, a globally operating biopharmaceutical company, is pleased to announce today that Swansea University Medical School is planning a clinical trial with Iota / kappa-carrageenan nasal spray as a COVID-19 prophylaxis for healthcare professionals (ICE-COVID) . The investigator-initiated study in Swansea will recruit 480 healthcare professionals who …
Read More »SARS-CoV-2 N439K mutation may be more infectious and resistant to antibodies than Wuhan strain
[ad_1] Researchers studied the effect of several SARS-CoV-2 mutations on its binding to the human angiotensin 2 converting enzyme using molecular dynamics simulations. They found that the N439K mutant binds more strongly than the original Wuhan strain, which could have implications for therapies such as monoclonal antibodies. The 2019 coronavirus …
Read More »A Review of Traditional Chinese Herbal Medicine in the Management of COVID-19
[ad_1] The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 59.65 million people worldwide and caused the deaths of over 1.4 million. The virus, first detected in late December 2019 in Wuhan, China, is the most significant public health problem since the 1918 …
Read More »Coronavirus vaccine | The vaccine from Oxford and AstraZeneca is 70% effective against covid-19 – Health
[ad_1] The UK laboratory AstraZeneca and the University of Oxford pointed this out this Monday in a joint statement the covid-19 vaccine they developed showed “70% effectiveness” in testing. “The efficacy and safety of this vaccine confirm this it will be very effective against covid-19 and will have an immediate …
Read More »Hyperimmune anti-SARS-CoV-2 globulin produced from a convalescent plasma pool has 3 antibody neutralizing activities
[ad_1] The severe acute respiratory syndrome virus coronavirus 2 (SARS-CoV-2) emerged from Wuhan, China in late 2019 and rapidly spread around the world, progressing into a full-fledged pandemic. As this is a new virus, scientists around the world immediately began work on developing a vaccine or effective therapeutic agents to …
Read More »Pfizer BioNTech: the new corona vaccine is 95% effective without serious side effects_Efficacy-Sohu
[ad_1] Pfizer BioNTech: The new corona vaccine is 95% effective and has no serious side effects_effectivenessSohu Pfizer CEO: Developing New High Temperature Resistant Corona Vaccine: IT and HealthcnBeta Pfizer CEO: New Corona Vaccine Trial Reached Safety Milestone and Submitted FDA ApplicationSina 8:01 Krypton | SF Express Denies Hong Kong Listing; …
Read More »After Pfizer’s announcement … an American health expert warns of “excessive optimism”
[ad_1] Pfizer recently said the vaccine’s effectiveness reached 90 percent, after conducting large-scale clinical trials, which means it will be able to curb the outbreak of the outbreak that appeared in China late last year. The head of the infectious disease department at the University of Alabama, Jenny Marazzo, asked …
Read More »Is the effectiveness greater than 90%? What do scientists think of Pfizer’s new corona vaccine? _Test-Sohu
[ad_1] Is the effectiveness greater than 90%? What do scientists think of Pfizer’s new corona vaccine? _testSohu Pfizer’s new corona vaccine research has made major strides, but the challenges of mass production, storage and transportation lieBBC Chinese Network After the great news of the new corona vaccine was announced in …
Read More »Pfizer CEO: 90% of the vaccine efficacy is disruptive, the announcement time is not disturbed by political factors_trial
[ad_1] Original title: Pfizer CEO: 90% Vaccine Effectiveness Is Subversive, Announcement Time Not Disturbed by Political Factors Each reporter: Li Menglin Each editor: Lan Suying Image source: CNN video screenshot “90% of the vaccine’s effectiveness is a game changer.“On November 9, after the first results of the phase III trial …
Read More »Results of the Phase 1 trial of the gorilla adenovirus vaccine for COVID-19
[ad_1] A recent study published on the prepress server bioRxiv* in October 2020 reports the development of a new vaccine based on a simian adenoviral vector obtained from a group C gorilla isolate called GRAd32. This could help accelerate vaccine development. Low seroprevalence for simian adenoviruses Monkey adenoviruses are isolated …
Read More »